Schond L. Greenway - Net Worth and Insider Trading
Schond L. Greenway Net Worth
The estimated net worth of Schond L. Greenway is at least $1 Million dollars as of 2024-12-28. Schond L. Greenway is the CFO of Mind Medicine Inc and owns about 216,617 shares of Mind Medicine Inc (MNMD) stock worth over $1 Million. Schond L. Greenway is also the CFO of Avalo Therapeutics Inc and owns about 1 shares of Avalo Therapeutics Inc (AVTX) stock worth over $8. Details can be seen in Schond L. Greenway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Schond L. Greenway has not made any transactions after 2023-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Schond L. Greenway
Schond L. Greenway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Schond L. Greenway owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Mind Medicine Inc (MNMD) .
Click here to see the complete history of Schond L. Greenway’s form 4 insider trades.
Insider Ownership Summary of Schond L. Greenway
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | CFO & Treasurer |
| MNMD | Mind Medicine Inc | 2023-12-26 | Chief Financial Officer |
Schond L. Greenway Latest Holdings Summary
Schond L. Greenway currently owns a total of 2 stocks. Among these stocks, Schond L. Greenway owns 216,617 shares of Mind Medicine Inc (MNMD) as of December 26, 2023, with a value of $1 Million and a weighting of 100%. Schond L. Greenway also owns 1 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2021, with a value of $8 and a weighting of 0%.
Latest Holdings of Schond L. Greenway
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNMD | Mind Medicine Inc | 2023-12-26 | 216,617 | 6.84 | 1,481,660 |
| AVTX | Avalo Therapeutics Inc | 2021-12-10 | 1 | 8.33 | 8 |
Holding Weightings of Schond L. Greenway
Schond L. Greenway Form 4 Trading Tracker
According to the SEC Form 4 filings, Schond L. Greenway has made a total of 4 transactions in Mind Medicine Inc (MNMD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Mind Medicine Inc is the sale of 5,652 shares on December 26, 2023, which brought Schond L. Greenway around $20,517.
According to the SEC Form 4 filings, Schond L. Greenway has made a total of 2 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 1 shares on December 10, 2021, which cost Schond L. Greenway around $3,503.
Insider Trading History of Schond L. Greenway
- 1
Schond L. Greenway Trading Performance
GuruFocus tracks the stock performance after each of Schond L. Greenway's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Schond L. Greenway is -42.82%. GuruFocus also compares Schond L. Greenway's trading performance to market benchmark return within the same time period. The performance of stocks bought by Schond L. Greenway within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Schond L. Greenway's insider trading performs compared to the benchmark.
Performance of Schond L. Greenway
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.59 | | | | | |
| Relative Return to S&P 500(%) | -28.69 | | | | | |
Schond L. Greenway Ownership Network
Schond L. Greenway Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Schond L. Greenway is the CFO & Treasurer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Schond L. Greenway made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 1,000 shares made by June Sherie Almenoff ,
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 0 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Schond L. Greenway Mailing Address
Above is the net worth, insider trading, and ownership report for Schond L. Greenway. You might contact Schond L. Greenway via mailing address: C/o Cerecor, Inc., 540 Gaither Road, Suite 400, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
